|
|
|
| Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Combined with Functional Splenic Embolization in the Treatment of Portal Hypertension in Cirrhotic Decompensated Liver |
| DONG Yang, LIANG Guijie, et al |
| The Third Hospital of Chengde, Heibei Chengde 067000, China |
|
|
|
|
Abstract Objective: To study the clinical efficacy of transjugular intrahepatic portosystemic shunt (TIPS) combined with functional splenic embolization (FSE) in the treatment of portal hypertension in decompensated cirrhosis. Methods: A total of 100 patients with cirrhotic portal hypertension were randomly divided into control group and treatment group. In the control group, partial splenic artery embolization (PSE) was performed, while in the treatment group, transjugular intrahepatic portosystemic shunt (TIPS) and functional splenic embolization (FSE) were performed. The clinical efficacy of the two groups was evaluated after one intervention. The main observations were portal vein pressure, liver function, spleen volume, blood count, coagulation, recent survival and safety indicators in both groups. Results: After treatment, the portal vein pressure, liver function, spleen volume, blood routine and coagulation function in the treatment group were better than those in the control group (P<0.05); there was no statistical difference between the two groups in terms of recent survival and safety (P>0.05). Conclusion: Transjugular intrahepatic portosystemic shunt (TIPS) combined with functional splenic embolization (FSE) has a good clinical effect in the treatment of portal hypertension in cirrhotic decompensated liver, which is worthy of clinical promotion.
|
|
|
|
|
|
[1] 赵君,廖星,赵晖.苦黄注射液治疗病毒性肝炎的有效性和安全性:随机对照试验的系统评价和Meta分析[J]中国中药杂志,2017,42(20):4007~4026.
[2] Lian JS,Zeng LY,Chen JY,etal.De novo combined lamivudine and adefovir dipivoxil therapy vs entecavirmono therapy for hepatitis B virus-related decompensated cirrhosis[J].World Gastroenterol,2019,19 (37):6278~6283.
[3] 彭姗姗,俞海英,钟艳丹.乙肝肝硬化患者肝病死亡的回顾性队列研究[J].预防医学,2019,31(11):1140~1146.
[4] 杨连粤,白雪莉.肝硬化门静脉高压症食管胃底静脉曲张破裂出血诊治专家共识(2019版)[J].中国实用外科杂志,2019,39(12):1241~1247.
[5] 何聪,王慧超,孔婧.肝硬化腹水中医治疗研究进展[J].新中医,2021,53(1):35~38.
[6] 周婷婷,潘月,李珍艳,等.经颈内静脉肝内门腔静脉分流术治疗门静脉高压伴食管胃底静脉曲张破裂出血的临床疗效[J].四川医学,2019,40(6):571~574.
[7] 高峰,刘玉娥,张婧娴.TIPS联合FSE治疗门静脉高压症患者的临床观察[J].影像研究与医学应用,2017,1(9):118~119.
[8] 李海霞,张凤朝,季彦芹,等.微球在功能性血流脾动脉栓塞治疗脾亢的疗效评价[J].解放军预防医学杂志,2016,34(3):10. |
|
|
|
2022, Vol. 28 
